Flexible and stretchable biosensors can offer seamless and conformable biological–
electronic interfaces for continuously acquiring high‐fidelity signals, permitting numerous …

In comparison with traditional clinical diagnosis methods, field–effect transistor (FET)–based
biosensors have the advantages of fast response, easy miniaturization and integration for …

Organic transistors possess inherent advantages such as flexibility, biocompatibility,
customizable chemical structures, solution‐processability, and amplifying capabilities …

Field effect transistor (FET)‐based nanoelectronic biosensor devices provide a viable route
for specific and sensitive detection of cancer biomarkers, which can be used for early stage …

Carcinoembryonic antigen (CEA) is a recognized biomarker for lung cancer and can be
used for early detection. However, the clinical value of CEA is not fully realized due to the …

Organic thin film transistors (OTFTs) enable rapid and label‐free high‐sensitivity detection of
target analytes due to their low cost, large‐area processing, biocompatibility, and inherent …

The ion-sensitive field effect transistor (ISFET) has emerged as a pivotal sensor device due
to its remarkable advantages, including label-free operation, miniaturization, high sensitivity …

Colorectal cancer (CRC) is one of the most treatable cancers, but high mortality levels have
been reported as a result of its asymptomatic nature in the very early stages of the disease …

Food contamination may occur at all stages from farm to fork, and these contaminants are
characterized by wide variety, trace amounts, and are susceptible to interference from …

The early determination of disease-related biomarkers can significantly improve the survival
rate of patients. Thus, a series of explorations for new diagnosis technologies, such as …